Showing results (141-150 of 588) with videos related to

Sort By:
Pageof 59
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients' Age: A Systematic Review and Meta-AnalysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
The Oncologist|October 7, 2011
Bevacizumab treatment for advanced breast cancerRicardo H Alvarez, Valentina Guarneri, Fikri Icli, et al.
The Oncologist|April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint InhibitorsAlberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Advances in Biochemical Engineering/Biotechnology|September 20, 2012
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic PotentialNaomi D'souza, Jorge Sans Burns, Giulia Grisendi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?Cesare Gridelli, Ilaria Attili, Chiara Bennati, et al.
Clinical Nutrition ESPEN|July 22, 2020
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trialsEmanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Critical Reviews in Oncology/Hematology|February 11, 2023
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitorsMiriam Grazia Ferrara, Lorenzo Belluomini, Annafrancesca Smimmo, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 14, 2019
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysisEmanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancerAlfredo Falcone, Gianluca Masi, Giacomo Allegrini, et al.
The Oncologist|July 25, 2008
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient managementValentina Guarneri, Simona Giovannelli, Guido Ficarra, et al.
Pageof 59